| [1] |
Asworth TR. A case of cancer in which cells similar to those in tumors were seen in the blood after death[J]. Aust Med J,1869,14:146-149.
|
| [2] |
Paterlini-Brechot P, Benali NL. Circulating tumor cells(CTC)detection: clinical impact and future directions[J]. Cancer Lett,2007,253(2):180-204.
|
| [3] |
Meng S,Tripathy D,Frenkel EP,et al. Circulating tumor cells in patients with breast cancer dormancy[J]. Clin Cancer Res,2004,10(24):8152-8162.
|
| [4] |
Mori M, Mimori K, Ueo H, et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease[J]. Int J Cancer, 1996,68(6):739-743.
|
| [5] |
Hu XC, Chow LW. Fine needle aspiration may shed breast cells into peripheral blood as determined by RT-PCR[J].Oncology,2000,59(3):217-222.
|
| [6] |
Zhe X, Cher ML, Bonfil RD. Circulating tumor cells: finding the needle in the haystack[J]. Am J Cancer Res, 2011,1(6):740-751.
|
| [7] |
Pachmann K, Clement JH, Schneider CP, et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer[J]. Clin Chem Lab Med,2005,43(6):617-627.
|
| [8] |
Rosenberg R, Gertler R, Friederichs J, et al. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood[J]. Cytometry,2002,49(4):150-158.
|
| [9] |
Vona G,Sabile A,Louha M,et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells[J]. Am J Pathol,2000,156(1):57-63.
|
| [10] |
Lalle M, De Rosa L, Marzetti L, et al. Detection of breast cancer cells in the bone marrow or peripheral blood: methods and prognostic significance[J]. Tumori,2000,86(3):183-190.
|
| [11] |
Alix-Panabières C, Vendrell JP, Pellé O, et al. Detection and characterization of putative metastatic precursor cells in cancer patients[J]. Clin Chem,2007,53(3):537-539
|
| [12] |
Nagrath S, Sequist LV, Maheswaran S, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology[J]. Nature,2007,450(7173):1235-1239.
|
| [13] |
Maheswaran S, Sequist LV, Nagrath S, et al. Detection of mutations in EGFR in circulating lung-cancer cells[J]. N Engl J Med,2008,359(4):366-377.
|
| [14] |
郑建,李丽. 循环肿瘤细胞在乳腺癌中的研究现状[J]. 现代肿瘤医学,2009,17(6):1158-1162.
|
| [15] |
Wang N, Shi L, Li H, et al. Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry: a valuable tool for diagnosis and prognosis evaluation[J]. Tumour Biol,2012,33(2):561-569.
|
| [16] |
Riethdorf S, Fritsche H, Müller V, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system[J]. Clin Cancer Res,2007,13(3):920-928.
|
| [17] |
Riethdorf S, Muller V, Zhang L, et al. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial[J]. Clin Cancer Res,2010,16(9):2634-2645.
|
| [18] |
Chong MH, Zhao Y, Wang J, et al. The dynamic change of circulating tumour cells in patients with operable breast cancer before and after chemotherapy based on a multimarker QPCR platform[J]. Br J Cancer,2012,106(10):1605-1610.
|
| [19] |
Racila E, Euhus D, Weiss AJ, et al. Detection and characterization of carcinoma cells in the blood[J]. Proc Natl Acad Sci U S A,1998,95(8):4589-4594.
|
| [20] |
Desitter I, Guerrouahen BS, Benali-Furet N, et al. A new device for rapid isolation by size and characterization of rare circulating tumor cells[J]. Anticancer Res, 2011, 31(2):427-441.
|
| [21] |
Weissenstein U, Schumann A, Reif M, et al. Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies[J]. BMC Cancer,2012,12:206.
|
| [22] |
Xu W, Cao L, Chen L, et al. Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy[J]. Clin Cancer Res, 2011, 7 (11):3783-3793.
|
| [23] |
Husemann Y, Geigl JB, Schubert F, et al. Systemic spread is an early step in breast cancer[J]. Cancer Cell,2008,13(1):58-68.
|
| [24] |
Biggers B, Knox S, Grant M, et al. Circulating tumor cells in patients undergoing surgery for primary breast cancer:preliminary results of a pilot study[J]. Ann Surg Oncol,2009,16(4):969-971.
|
| [25] |
Lobodasch K, Frohlich F, Rengsberger M, et al. Quantification of circulating tumour cells for the monitoring of adjuvant therapy in breast cancer: an increase in cell number at completion of therapy is a predictor of early relapse[J]. Breast,2007,16(2):211-218.
|
| [26] |
Budd GT, Cristofanilli M, Ellis MJ, et al. Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer[J]. Clin Cancer Res,2006,12(21):6403-6409.
|
| [27] |
De Giorgi U, Valero V, Rohren E, et al. Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer[J]. Ann Oncol,2010,21(1):33-39.
|
| [28] |
Mikhitarian K, Martin RH, Ruppel MB, et al. Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study[J]. BMC Cancer,2008,8:55.
|
| [29] |
蔡清清,黄慧强, 林天歆, 等. 乳腺癌患者外周血中循环癌细胞的检测及其临床意义[J].癌症,2005,24(7):5.
|
| [30] |
Nole F, Munzone E, Zorzino L, et al. Variation of circulating tumor cell levels during treatment of metastatic breast cancer:prognostic and therapeutic implications[J]. Ann Oncol,2008,19(5):891-897.
|
| [31] |
Hartkopf AD,Wagner P, Wallwiener D,et al. Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer[J]. Anticancer Res,2011,31(3):979-984.
|
| [32] |
Pachmann K, Camara O, Kavallaris A, et al. Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring[J]. Breast Cancer Res,2005,7(6):R975-R979.
|
| [33] |
Smerage JB, Hayes DF. The measurement and therapeutic implications of circulating tumour cells in breast cancer[J]. Br J Cancer,2006,94(1):8-12.
|
| [34] |
Shaw JA, Page K, Blighe K, et al. Genomic analysis of circulating cell-free DNA infers breast cancer dormancy[J].Genome Res,2012,22(2):220-231.
|
| [35] |
Nadal R, Fernandez A, Sanchez-Rovira P, et al. Biomarkers characterization of circulating tumour cells in breast cancer patients[J]. Breast Cancer Res,2012,14(3):R71.
|
| [36] |
Fehm T, Becker S, Duerr-Stoerzer S, et al. Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status[J]. Breast Cancer Res,2007,9(5):R74.
|
| [37] |
Payne RE, Yague E, Slade MJ, et al. Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients[J]. Pharmacogenomics,2009,10(1):51-57.
|
| [38] |
Stojadinovic A, Mittendorf EA, Holmes JP, et al.Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study[J]. Ann Surg Oncol,2007,14(12):3359-3368.
|
| [39] |
Gates JD, Benavides LC, Stojadinovic A, et al. Monitoring circulating tumor cells in cancer vaccine trials [J]. Hum Vaccin,2008,4(5):389-392.
|
| [40] |
Xenidis N, Markos V, Apostolaki S, et al. Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer[J]. Ann Oncol,2007,18(10):1623-1631.
|
| [41] |
Lucci A,Hall CS,Lodhi AK,et al. Circulating tumour cells in non-metastatic breast cancer: a prospective study[J]. Lancet Oncol,2012,13(7):688-695.
|
| [42] |
Xenidis N, Ignatiadis M, Apostolaki S, et al. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer[J]. J Clin Oncol,2009,27(13):2177-2184.
|
| [43] |
Munzone E, Nole F, Goldhirsch A, et al. Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer[J]. Clin Breast Cancer,2010,10(5):392-397.
|
| [44] |
Pierga JY, Bidard FC, Mathiot C, et al. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial[J]. Clin Cancer Res,2008,14(21):7004-7010.
|
| [45] |
Wang J, Cao MG, You CZ, et al. A preliminary investigation of the relationship between circulating tumor cells and cancer stem cells in patients with breast cancer[J]. Cell Mol Biol,2012,58 (Suppl):1641-1645.
|